CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Stephen F. Betz sold $216K of Crinetics Pharmaceuticals, Inc.
Sold$215,762
$23.97Price
9,000Shares
−7%Stake
What CRNX did after the filing
- The stock from Wed, Apr 6 close, $24.03
- −17.6%
- S&P 500, same days
- −12.8%
Measured over 30 trading days, to the May 19 close.
Traded Mon, Apr 4. Filed Wed, Apr 6, 3:08 PM ET, during the session. Returns use the Apr 6 close and the May 19 close. Not investment advice.